Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
AKAN: Akanda Corp. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
AKAN
The Story
AKAN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-69.2% / yr
Operating margin
-2022.7%
ROIC
-232.4%
Financially safe
Stretched
Debt / equity
-1.32×
Interest coverage
-5.6×
Current ratio
0.58×
Akanda Corp.
AKAN
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Akanda Corp.
AKAN
NASDAQ
·
USD
·
Closed
$5.31
−16.90%
$5.31
−$1.08 (16.90%)
52W Range
1th
pctl
Volume
0.10×
avg
Mkt Cap
171863
USD
P/E
-0.0
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.10×
avg
Market Cap
171863
USD
P/E Ratio
-0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings